Who
David B. Weiner
Director
Company insider
Files Form 4 as: Director, Inovio Pharmaceuticals.
In numbers
- Trades disclosed
- 139
- Buys
- 0
- Sells
- 18
- Bought
- $0
- Sold
- $914K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 Mar 2016
- Last trade
- 20 May 2026
- Last filed
- 21 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,800 at $0.00 | filing |
| 20 May 2026filed 21 May 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,200 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —972 | filing |
| 26 Feb 2026filed 27 Feb 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —972 | filing |
| 21 May 2025filed 21 May 2025 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,167 at $0.00 | filing |
| 21 May 2025filed 21 May 2025 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,167 | filing |
| 26 Feb 2025filed 28 Feb 2025 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
| 26 Feb 2025filed 28 Feb 2025 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
| 26 Feb 2025filed 28 Feb 2025 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —972 | filing |
| 26 Feb 2025filed 28 Feb 2025 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —972 | filing |
| 21 May 2024filed 22 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,917 at $0.00 | filing |
| 21 May 2024filed 22 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,167 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,166 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | INO Inovio PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,166 | filing |
| 26 Feb 2024filed 28 Feb 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
| 26 Feb 2024filed 28 Feb 2024 | INO Inovio Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —972 at $0.00 | filing |
News
Critical Analysis: Pyxis Oncology (NASDAQ:PYXS) versus Inovio Pharmaceuticals (NASDAQ:INO)INO · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name David B. Weiner; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.